[Federal Register: April 2, 2007 (Volume 72, Number 62)]
[Notices]
[Page 15698]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02ap07-75]
[[Page 15698]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Evaluation of the Immune Response to a Modified
Dosing Schedule of the Quadrivalent HPV Vaccine, Potential Extramural
Project (PEP) 2007-R-03
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Time and Date: 12 p.m.-4 p.m., May 17, 2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review,
discussion, and evaluation of ``The Immune Response to a Modified
Dosing Schedule of the Quadrivalent HPV Vaccine,'' PEP 2007-R-03.
Contact Person for More Information: Christine J. Morrison, PhD,
Scientific Review Administrator, Office of the Chief Science
Officer, CDC, 1600 Clifton Road NE, Mailstop D-72, Atlanta, GA
30333, Telephone (404) 639-3098.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: March 26, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-6036 Filed 3-30-07; 8:45 am]
BILLING CODE 4163-18-P